Immunosuppressants protein tyrosine kinase Neuronal Signaling PI3K / Akt / mTOR Metabolism Cell Cycle Epigenetics Cytoskeletal Signaling Angiogenesis DNA damage Proteases Apoptosis Mitogen-activated protein kinase (MAPK) Endocrinology & Hormones GPCR & G Protein Transmembrane Transporters Protein tyrosine kinase /JAK / STAT TGF-beta / Smad Stem Cells & Wnt Nuclear transcription factor (NF-κB) Ubiquitin Microbiology Autophagy
ChemicalBook >   Product Catalog >  Biochemical Engineering >  Inhibitors

Inhibitors

Immunosuppressants protein tyrosine kinase Neuronal Signaling PI3K / Akt / mTOR Metabolism Cell Cycle Epigenetics Cytoskeletal Signaling Angiogenesis DNA damage Proteases Apoptosis Mitogen-activated protein kinase (MAPK) Endocrinology & Hormones GPCR & G Protein Transmembrane Transporters Protein tyrosine kinase /JAK / STAT TGF-beta / Smad Stem Cells & Wnt Nuclear transcription factor (NF-κB) Ubiquitin Microbiology Autophagy
More
Less

Inhibitor refers to substance that can hinder the chemical reactions, biological reactions (including immune response) and biological activity. In present time, commonly used inhibitors include immunosuppressants and inhibitors.

1. Immunosuppressive agents: immunosuppressants system refers to drug that can reduce the immune response. It can selectively suppress certain steps of the immune response and immune cells. Immune response refers to the body’s response to a variety of pathogenic substances. Some reactions are favorable to the body and can enhance the body's resistance to disease; some have adverse effects on the body and can cause tissue damage or disorders of physiological functions (allergy). Therefore, patients suffering from allergic reactions being harmful to the body should be subject to the treatment of immunosuppressant to affect the related immune processes and reduce the immune response of the body.

For the treatment of various autoimmune diseases and weakening the tissue incompatibility, it has been developed of a variety of immunosuppressive agents, some of which have been widely used in clinical practice. Commonly used immunosuppressants include glucocorticoids (prednisone, prednisolone, etc.), alkylating agents (nitric oxide mustard, cyclophosphamide, thiotepa, busulfan, etc.), and antimetabolites (6- mercaptopurine, azathioprine, methotrexate, etc.).

The mechanism of immunosuppressants, though not entirely clear, but is characterized by the following several aspects:
① most kinds of immunosuppressants can simultaneously inhibit cellular and humoral immunity and can be used for organ transplantation and autoimmune disease.
②Its inhibitory effect is strong for the primary immune response while the inhibitory effect against secondary response is weak.
③It can simultaneously act on normal and pathological immunity, therefore, can often lead to some complications.
④These drugs often have strong with serious adverse reactions.

2. Enzyme inhibitors: Enzyme inhibitors refer to compounds or drugs being capable of binding to enzyme and inhibit the enzymatic activity. It is clinically often applied of enzyme inhibitors to specially interfere with certain metabolic system to achieve the therapeutic purposes. For example, people use monoamine oxidase inhibitors as antidepressants; use carbonic anhydrase inhibitors as diuretics; use dopa decarboxylase inhibitors as antihypertensive drugs and use antibiotics such as penicillin, cephalosporins belonging to cell wall synthesis inhibitors. Enzyme inhibitors have applications in veterinary medicine and agriculture. In addition, people can also apply enzyme inhibitors to study the mechanism of the enzyme and metabolic pathways.

Enzyme inhibitors often have similar structure with their natural substrates. For designing the inhibitors according modification of natural substrate, people should first analyze and decide the function of each part of the molecule in binding with enzymes: for binding or not binding or repulsion; secondly, people should know the degree of tolerance of the binding site to the adjacent steric hindrance. Then people can replace each functional group to regulate the strength of interaction with the enzyme.

Inhibitors can be divided into reversible and irreversible, two classes. (1)Inhibitors binding with enzyme through non-covalent bonds are called reversible inhibitor. (2)Inhibitors binding to the enzyme via a covalent bond are irreversible inhibitors with strong binding affinity. They will not be affected by concentration change process such as dialysis or dilution after binding to the enzyme.

Click on the specific product, view the latest prices of the products, information, serving information

Structure:
Chemical Name:
NH125
CAS:
278603-08-0
MF:
C27H45N2.I
Structure:
Chemical Name:
IWP L6
CAS:
1427782-89-5
MF:
C25H20N4O2S2
Structure:
Chemical Name:
IKK 16
CAS:
873225-46-8
MF:
C28H29N5OS
Structure:
Chemical Name:
SAR 131675
CAS:
1433953-83-3
MF:
C18H22N4O4
Structure:
Chemical Name:
ZM 323881 hydrochloride
CAS:
193000-39-4
MF:
C22H19ClFN3O2
Structure:
Chemical Name:
CNX-2006
CAS:
1375465-09-0
MF:
C26H27F4N7O2
Structure:
Chemical Name:
SKLB1002
CAS:
1225451-84-2
MF:
C13H12N4O2S2
Structure:
Chemical Name:
b-AP15
CAS:
1009817-63-3
MF:
C22H17N3O6
Structure:
Chemical Name:
UNC 669
CAS:
1314241-44-5
MF:
C15H20BrN3O
Structure:
Chemical Name:
Entospletinib (GS-9973)
CAS:
1229208-44-9
MF:
C23H21N7O
Structure:
Chemical Name:
WZ4003
CAS:
1214265-58-3
MF:
C25H29ClN6O3
Structure:
Chemical Name:
LRRK2-kinase inhibitor
CAS:
1285515-21-0
MF:
C24H18FN3O2
Structure:
Chemical Name:
RO3280
CAS:
1062243-51-9
MF:
C27H35F2N7O3
Structure:
Chemical Name:
Carbonic Anhydrase IX/XII Inhibitor II(U-104)
CAS:
178606-66-1
MF:
C13H12FN3O3S
Structure:
Chemical Name:
VUF 10166
CAS:
155584-74-0
MF:
C13H15ClN4
Structure:
Chemical Name:
PF 543
CAS:
1415562-82-1
MF:
C27H31NO4S
Structure:
Chemical Name:
XL413 (BMS-863233)
CAS:
1169562-71-3
MF:
C14H13Cl2N3O2
Structure:
Chemical Name:
UNC0379
CAS:
1620401-82-2
MF:
C23H35N5O2
Structure:
Chemical Name:
5-(2-Phenyl-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-ylamine
CAS:
865362-74-9
MF:
C18H13N7
Structure:
Chemical Name:
ADX-47273
CAS:
851881-60-2
MF:
C20H17F2N3O2
Structure:
Chemical Name:
CAY10505
CAS:
1218777-13-9
MF:
C14H8FNO3S
Structure:
Chemical Name:
Ki16198
CAS:
355025-13-7
MF:
C24H25ClN2O5S
Structure:
Chemical Name:
LGK-974
CAS:
1243244-14-5
MF:
C23H20N6O
Structure:
Chemical Name:
(Z)-3-(3-(3,5-bis(trifluoroMethyl)phenyl)-1H-1,2,4-triazol-1-yl)-1-(3,3-
CAS:
1421919-75-6
MF:
C16H10F8N4O
Structure:
Chemical Name:
GNE-9605
CAS:
1536200-31-3
MF:
C17H20ClF4N7O
Structure:
Chemical Name:
SD-208
CAS:
627536-09-8
MF:
C17H10ClFN6
Structure:
Chemical Name:
A 205804
CAS:
251992-66-2
MF:
C15H12N2OS2
Structure:
Chemical Name:
Levobetaxolol HCL
CAS:
116209-55-3
MF:
C18H30ClNO3
Structure:
Chemical Name:
WZ3146
CAS:
1214265-56-1
MF:
C24H25ClN6O2
Structure:
Chemical Name:
PIK-293
CAS:
900185-01-5
MF:
C22H19N7O
Structure:
Chemical Name:
TG 100713
CAS:
925705-73-3
MF:
C12H10N6O
Structure:
Chemical Name:
VU 0364770
CAS:
61350-00-3
MF:
C12H9ClN2O
Structure:
Chemical Name:
JNK-IN-8
CAS:
1410880-22-6
MF:
C29H29N7O2
Structure:
Chemical Name:
N4-(9-Ethyl-9H-carbazol-3-yl)-N2-(3-Morpholin-4-yl-propyl)-pyriMidine-2,4-diaMine
CAS:
1380432-32-5
MF:
C25H30N6O
Structure:
Chemical Name:
Edoxaban (tosylate Monohydrate)
CAS:
1229194-11-9
MF:
C31H38ClN7O7S2
Structure:
Chemical Name:
7-benzyl-10-(2-Methylbenzyl)-2,6,7,8,9,10-hexahydroiMidazo[1,2-a]pyrido[4,3-d]pyriMidin-5(3H)-one
CAS:
41276-02-2
MF:
C24H26N4O
Structure:
Chemical Name:
S-Ruxolitinib (INCB018424)
CAS:
941685-37-6
MF:
C17H18N6
Structure:
Chemical Name:
TMP269
CAS:
1314890-29-3
MF:
C25H21F3N4O3S
Structure:
Chemical Name:
FGFR inhibitor
CAS:
848318-25-2
MF:
C18H15N2NaO4
Structure:
Chemical Name:
UNC2250
CAS:
1493694-70-4
MF:
C24H36N6O2
Structure:
Chemical Name:
FLI-06
CAS:
313967-18-9
MF:
C25H30N2O5
Structure:
Chemical Name:
5-[6-(4-Methoxyphenyl)pyrazolo[1,5-a]
CAS:
1062368-49-3
MF:
C22H16N4O
Structure:
Chemical Name:
WS6
CAS:
1421227-53-3
MF:
C29H31F3N6O3
Structure:
Chemical Name:
BMH21
CAS:
896705-16-1
MF:
C21H20N4O2
Structure:
Chemical Name:
PD168393
CAS:
194423-15-9
MF:
C17H13BrN4O
Structure:
Chemical Name:
Cyclophosphamide
CAS:
50-18-0
MF:
C7H15Cl2N2O2P
Structure:
Chemical Name:
MMP-2/MMP-9 INHIBITOR IV
CAS:
292605-14-2
MF:
C15H14O3S2
Structure:
Chemical Name:
JNJ 1661010
CAS:
681136-29-8
MF:
C19H19N5OS
Structure:
Chemical Name:
Sb-742457
CAS:
607742-69-8
MF:
C19H19N3O2S
Structure:
Chemical Name:
3-(2,4-Dichloro-5-methoxyphenyl)-2,3-dihydro-2-thioxo-4(1H)-quinazolinone
CAS:
338967-87-6
MF:
C15H10Cl2N2O2S
Structure:
Chemical Name:
Ro 3306
CAS:
872573-93-8
MF:
C18H13N3OS2
Structure:
Chemical Name:
Voreloxin
CAS:
175414-77-4
MF:
C18H19N5O4S
Chemical Name:
ENMD-2076 (Tartrate)
CAS:
1291074-87-7
MF:
C21H25N7.x(C4H6O6)
Structure:
Chemical Name:
2-ButynaMide, N-[4-[(3-broMophenyl)aMino]-6-quinazolinyl]-
CAS:
194423-06-8
MF:
C18H13BrN4O
Structure:
Chemical Name:
Nutlin-3b
CAS:
675576-97-3
MF:
C30H30Cl2N4O4
Structure:
Chemical Name:
lenvatinib Mesylate
CAS:
857890-39-2
MF:
C22H23ClN4O7S
Structure:
Chemical Name:
SGI-1027
CAS:
1020149-73-8
MF:
C27H23N7O
Structure:
Chemical Name:
OTX015
CAS:
202590-98-5
MF:
C25H22ClN5O2S
Structure:
Chemical Name:
VE 822
CAS:
1232416-25-9
MF:
C24H25N5O3S
Structure:
Chemical Name:
Encorafenib (LGX818)
CAS:
1269440-17-6
MF:
C22H27ClFN7O4S
Structure:
Chemical Name:
AHAS inhibitor
CAS:
219793-45-0
MF:
C19H12ClNO6S
Structure:
Chemical Name:
Tacrolimus Monohydrate
CAS:
109581-93-3
MF:
C44H71NO13
Structure:
Chemical Name:
CCG-1423
CAS:
285986-88-1
MF:
C18H13ClF6N2O3
Structure:
Chemical Name:
PF-04620110
CAS:
1109276-89-2
MF:
C21H24N4O4
Structure:
Chemical Name:
Refametinib
CAS:
923032-37-5
MF:
C19H20F3IN2O5S
Structure:
Chemical Name:
WAY-600
CAS:
1062159-35-6
MF:
C28H30N8O
Structure:
Chemical Name:
CEP 33779
CAS:
1257704-57-6
MF:
C24H26N6O2S
Structure:
Chemical Name:
Dolutegravir sodium
CAS:
1051375-19-9
MF:
C20H20F2N3NaO5
Structure:
Chemical Name:
Dovitinib Dilactic acid (TKI258 Dilactic acid)
CAS:
852433-84-2
MF:
C24H27FN6O4
Structure:
Chemical Name:
EI1
CAS:
1418308-27-6
MF:
C23H26N4O2
Structure:
Chemical Name:
NSC319726
CAS:
71555-25-4
MF:
C11H14N4S
Structure:
Chemical Name:
JIB-04
CAS:
199596-05-9
MF:
C17H13ClN4
Structure:
Chemical Name:
MK8745
CAS:
885325-71-3
MF:
C20H19ClFN5OS
Structure:
Chemical Name:
SGC-CBP30
CAS:
1613695-14-9
MF:
C28H33ClN4O3
Structure:
Chemical Name:
ML167
CAS:
1285702-20-6
MF:
C19H17N3O3
Structure:
Chemical Name:
BroMosporine
CAS:
1619994-69-2
MF:
C17H20N6O4S
Structure:
Chemical Name:
CW069
CAS:
1594094-64-0
MF:
C23H21IN2O3
Structure:
Chemical Name:
GNE-0877
CAS:
1374828-69-9
MF:
C14H16F3N7
Structure:
Chemical Name:
HS-173
CAS:
1276110-06-5
MF:
C21H18N4O4S
Structure:
Chemical Name:
Nexturastat A
CAS:
1403783-31-2
MF:
C19H23N3O3
Structure:
Chemical Name:
UNC2881
CAS:
1493764-08-1
MF:
C25H33N7O2
Structure:
Chemical Name:
LY2584702
CAS:
1082949-67-4
MF:
C21H19F4N7
Structure:
Chemical Name:
GABAPENTIN-D6 HYDROCHLORIDE
CAS:
60142-95-2
MF:
C9H12ClD6NO2
Structure:
Chemical Name:
4,4'-propylenebis(piperazine-2,6-dione)
CAS:
21416-67-1
MF:
C11H16N4O4
Structure:
Chemical Name:
SB269970 HCl
CAS:
261901-57-9
MF:
C18H28N2O3SHCl
Structure:
Chemical Name:
C 646
CAS:
328968-36-1
MF:
C24H19N3O6
Structure:
Chemical Name:
PYR 41
CAS:
418805-02-4
MF:
C17H13N3O7
Structure:
Chemical Name:
NVP-BSK805
CAS:
1092499-93-8
MF:
C27H28F2N6O
Structure:
Chemical Name:
3-(1-Methyl-1H-pyrazol-4-yl)-5-oxo-N-(2-pyridinylmethyl)-5H-benzo[4,5]cyclohepta[1,2-b]pyridine-7-methanesulfonamide
CAS:
1001917-37-8
MF:
C25H21N5O3S
Structure:
Chemical Name:
E-3810
CAS:
1058137-23-7
MF:
C26H25N3O4
Structure:
Chemical Name:
BAM7
CAS:
331244-89-4
MF:
C21H19N5O2S
Structure:
Chemical Name:
DCC-2618
CAS:
1225278-16-9
MF:
C26H21F2N5O3
Structure:
Chemical Name:
pf-5274857
CAS:
1373615-35-0
MF:
C20H25ClN4O3S
Structure:
Chemical Name:
ML 133 Hydrochloride
CAS:
1222781-70-5
MF:
C19H20ClNO
Structure:
Chemical Name:
GSK2656157
CAS:
1337532-29-2
MF:
C23H21FN6O
Structure:
Chemical Name:
GSK J4 HCl
CAS:
1373423-53-0
MF:
C24H27N5O2
Structure:
Chemical Name:
G-749
CAS:
1457983-28-6
MF:
C25H25BrN6O2
Structure:
Chemical Name:
ANA12
CAS:
219766-25-3
MF:
C22H21N3O3S
Structure:
Chemical Name:
4-(4-Methyl-1-piperazinyl)-7-nitrobenzofurazane 3-oxide
CAS:
58131-57-0
MF:
C11H13N5O4
Structure:
Chemical Name:
7-Methyl-5-[(3-piperazin-1-ylMethyl)-1,2,4-oxadiazol-5-yl-]-2-[4-(trifluoroMethoxy)benzyl]-2,3-dihydro-1H-isoindol-1-one Methanesulphonate
CAS:
802904-66-1
MF:
C19H17ClN2O3S